In both treatment groups, a slight trend for higher rates of any AEs, SAEs and drug-related AEs was seen in subjects with RI.
← all excerpts
Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment.
1
—
—